$ Value
$0
Shares
750,000
Price
$0
Filed
Jul 29
Insider
Name
Cudahy Theresa Ellen
Title
COO and Secretary
CIK
0001827522
Roles
Transaction Details
Transaction Date
2025-07-25
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
750,000
Footnotes
On July 25, 2025 ("Grant Date"), the Company granted Ms. Cudahy 750,000 restricted stock units ("RSUs") with tandem dividend equivalent rights under the Company's 2020 Omnibus Incentive Plan (the "Plan"). Each RSU represents a contingent right to receive one share of common stock. | The RSUs granted will vest in four tranches of 187,500 each upon the date the Board determines that the applicable performance condition has been achieved: (i) the common stock of the Company achieves a 10 day volume weighted average price (VWAP) of $6.50; (ii) the common stock achieves a 10 day VWAP of $7.50; (iii) the common stock achieves a 10 day VWAP of $9.50; and (iv) the common stock achieves a 10 day VWAP of $11.50. In the event that the performance conditions are not met, the RSUs granted will vest in four equal installments of 187,500 on each of the first, second, third and fourth anniversaries of the Grant Date, and will be settled upon vesting (or within 30 days thereafter). All vesting events are subject to continued employment on each applicable vesting date.
Filing Info
Cudahy Theresa Ellen's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-12-10 | CURI | ▼ | $29K |
| 2025-11-20 | CURI | ▼ | $51K |
| 2025-11-13 | CURI | ▼ | $28K |
| 2025-07-25 | CURI | A | $0 |
Other Insiders at CURI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HUBERMAN JONATHAN | — | — | 2026-02-04 |
| HENDRICKS JOHN S | — | — | 2026-02-04 |
| Blank Matthew | — | — | 2026-02-04 |
| Nikzad Michael | — | — | 2026-02-04 |
|
Stinchcomb Clinton Larry
President and CEO
|
— | — | 2026-03-11 |
| Hendricks Elizabeth Ann | — | — | 2026-02-04 |
| Keeley Patrick J. | — | — | 2026-02-04 |
| Hendricks Andrew | — | — | 2026-02-04 |
|
Hayden Phillip Brady
Chief Financial Officer
|
— | — | 2026-02-10 |
|
Reed Rebecca R
Gen Counsel
|
— | — | 2026-02-10 |
|
Vilade John Thomas Jr
Chief Commercial Officer
|
— | — | 2026-02-10 |